Acquired resistance to gemcitabine and cross-resistance in human pancreatic cancer clones-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Acquired resistance to gemcitabine and cross-resistance in human pancreatic cancer clones

Published:2015-01 Issue:1 Volume:26 Page:90-100
ISSN:0959-4973
Container-title:Anti-Cancer Drugs
language:en
Short-container-title:

Author:

Yoneyama Hiroshi,Takizawa-Hashimoto Asako,Takeuchi Osamu,Watanabe Yukiko,Atsuda Koichiro,Asanuma Fumiki,Yamada Yoshinori,Suzuki Yukio

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Pharmacology (medical),Pharmacology,Oncology

Reference42 articles.

1. Cancer statistics, 2012.;Siegel;CA Cancer J Clin,2012

2. Pancreatic cancer.;Vincent;Lancet,2011

3. 3rd, Moore MJ, Andersen J, Green MR, Rothenberg ML, Modiano MR, et al.. Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial.;Burris;J Clin Oncol,1997

4. . Gruppo Oncologico Italia Meridionale (GOIM); Gruppo Italiano per lo Studio dei Carcinomi dellApparato Digerente (GISCAD); Gruppo Oncologico Italiano di Ricerca Clinica (GOIRC). Randomized phase III trial of gemcitabine plus cisplatin compared with single-agent gemcitabine as first-line treatment of patients with advanced pancreatic cancer: the GIP-1 study.;Colucci;J Clin Oncol,2010

5. . Phase III randomized comparison of gemcitabine versus gemcitabine plus capecitabine in patients with advanced pancreatic cancer.;Cunningham;J Clin Oncol,2009

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Myofibrillogenesis Regulator‐1 Regulates the Ubiquitin Lysosomal Pathway of Notch3 Intracellular Domain Through E3 Ubiquitin‐Protein Ligase Itchy Homolog in the Metastasis of Non‐Small Cell Lung Cancer;Advanced Science;2024-02-11

2. Glycogen synthase kinase 3β: the nexus of chemoresistance, invasive capacity, and cancer stemness in pancreatic cancer;Cancer Drug Resistance;2024-01-31

3. Prognostic value of RRM1 and its effect on chemoresistance in pancreatic cancer;Cancer Chemotherapy and Pharmacology;2023-12-01

4. Investigating the regulatory role of miRNAs as silent conductors in the management of pathogenesis and therapeutic resistance of pancreatic cancer;Pathology - Research and Practice;2023-11

5. Targeting AHR Increases Pancreatic Cancer Cell Sensitivity to Gemcitabine through the ELAVL1-DCK Pathway;International Journal of Molecular Sciences;2023-08-24

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3